This poster presents a retrospective case-control evaluation of weight and body composition outcomes with liraglutide in individuals with obesity and well-treated hypothyroidism. It summarizes real-world clinical data comparing patients receiving stable levothyroxine therapy with matched euthyroid controls. The aim is to visually synthesize treatment effectiveness, body composition changes, and key predictors of weight loss, and to address the generalizability of GLP-1 receptor agonist therapy for weight management in patients with hypothyroidism.